Episode 274: Advancing Cancer Immunotherapy with Dr. Besim Ogretmen of Lipo‑Immuno Tech & MUSC
About this episode
Dr. Besim Ogretmen discusses advancements in cancer immunotherapy and the development of novel treatments at the 2026 SCbio Annual Conference.
Recorded at the 2026 SCbio Annual Conference in Charleston, Heather and Matthew are joined by Dr. Besim Ogretmen, an internationally recognized cancer researcher at MUSC and Co-Founder and CEO of Lipo‑Immuno Tech. Dr. Ogretmen shares how his team is developing novel chemoimmunotherapy approaches designed to enhance immune cell function and improve outcomes for patients with advanced cancers. We also discussed building a biotech company from academic research, securing non‑dilutive funding, scaling manufacturing, and leveraging AI to support research and regulatory efforts. Tune in for an inside look at how their unique treatments are changing and extending patients’ lives!
More episodes of Taking the Pulse: a Health Care and Life Sciences Podcast
- Episode 278: Equipping Health Systems with the Right AI Solutions with Dr. Mark Sendak of Vega Health
- Episode 277: M&A Trends and Growth in the Life Sciences Industry with John Erwin of Maynard Nexsen
- Episode 276: Educating the Life Sciences Workforce with Wake Tech’s Leslie Isenhour
- Episode 273: Navigating FDA Regulation for Life Sciences Companies with Christin Carey of Maynard Nexsen
- Episode 272: Humanism and Transplant Care with Dr. Joseph Scalea of MUSC
- Episode 271: Advancing Neurotrauma Treatments with Ken Webb of NeuroHope Therapeutics
Explore listener stats, chart rankings, contacts and more on the Taking the Pulse: a Health Care and Life Sciences Podcast podcast page.